AI Therapeutics Company

AI Therapeutics develops drugs for rare diseases and cancer.

Last Funding Type: Series C
Headquarters: Guilford, Connecticut, United States
Investor Type:
Investment Stage: N/A
Total Funding: 98000000
Employee Number: 51-100
Funding Status: M&A
Industry: Medical BioTech
Technology: ['BioTech & HealthTech']
Number Of Exists: N/A
Estimated Revenue: $1M to $10M
Last Funding Date: 2017-03-30
Founded Date: 2013-01-01
Investors Number: 2.0